
Eli Lilly Revenue Surges 45% in 2025 as GLP-1 Drugs Drive Record Sales
Eli Lilly and Company reported record financial results in 2025, with total revenue rising 45% year over year to $65.18 billion, up from $45.04 billion

Eli Lilly and Company reported record financial results in 2025, with total revenue rising 45% year over year to $65.18 billion, up from $45.04 billion

Money In Focus has announced a strategic partnership with Revamont, an international luxury travel atelier specializing in bespoke journeys and exclusive access. The collaboration is

Google.org and the Johnson & Johnson Foundation have announced a $10 million philanthropic initiative designed to help rural healthcare workers across the United States develop

Social media has transformed the way people communicate, consume information, and perceive success. But beneath the curated images of luxury vacations, designer purchases, and seemingly

Abridge CEO and co-founder Shiv Rao says the company spent nearly five years navigating uncertainty before finding product-market fit in the rapidly evolving artificial intelligence

As the countdown to the FIFA World Cup 2026 accelerates, Dallas is positioning itself as one of the most attractive host cities for international visitors.

Fortunes at the top of the global wealth ladder are shifting in real time, mirroring volatility across equities, commodities, and currencies. The latest data from

Neurocrine Biosciences has agreed to acquire Soleno Therapeutics in a $2.9 billion all-cash transaction, reinforcing its strategic expansion into endocrinology and rare disease treatments. Under

The Eli Lilly and Company is accelerating its push into artificial intelligence with a deal worth up to $2.75 billion with Insilico Medicine, signaling a

Exscape Group today announced a strategic partnership with Buckeye Landscape Service, marking a significant milestone in the company’s continued expansion across the Columbus metropolitan area.